Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avicanna Inc T.AVCN

Alternate Symbol(s):  AVCNF

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse range of proprietary products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca is a medical cannabis care platform and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. Aureus Santa Mart is a commercial-stage business providing a various forms CBD, THC and CBG to the Company's international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products.


TSX:AVCN - Post by User

Comment by Russell1on Mar 08, 2021 2:09pm
109 Views
Post# 32744541

RE:Gonna sell at 1.25

RE:Gonna sell at 1.25I would put this solidly on management's lap mate. I keep saying it, there is not enough volume on AVCN for it to be worthwhile for any real shorts. The last short report I checked had around 3% of trades as shorts, no money in that with low volume. Friendly advice mate, maybe hold for another 3-4 months when this company will need another raise, they will use what's left in the bank to promote their stock (terribly btw) and spike the price temporarily to raise. Move out then. Quick note about the dilution. Original share count on ipo was around 20m shares outstanding, they are now up to around 50m shares. 2.5x dilution since ipo! So your target price of $2.50 is diluted down to $1. Do the math mate, now do the math after the next raise, and the next raise. Are you beginning to see what I have been trying to get across? Maybe my frustration having bought in above $7? The company trolls on this board can say whatever they care to but the proof is in the pudding. Good luck mate
<< Previous
Bullboard Posts
Next >>